NEW YORK (GenomeWeb) – Coriell Life Sciences announced today that it has partnered with Psyche Systems to develop an end-to-end sample management and interpretation and reporting system for pharmacogenomics and women's health molecular diagnostics.
The service will provide the companies' mutual laboratory customers with a way to manage genetic samples and to send actionable reporting to clinicians seeking to make treatment decisions. They will initially focus on a unified pipeline for pharmacogenomics and women's health genetic testing, Coriell said, but they also plan to expand into other types of genetic testing at some point in the future.
"We are delighted to partner with Psyche Systems," Jeffrey Shaman, Coriell's director of business development, said in a statement. "We believe this integration is a perfect fit for customers who need to marry rigorous laboratory sample management with immediately marketable and actionable clinical reporting."
Further terms of the deal were not disclosed.
The new service and technology will be available to new and existing customers starting in the fourth quarter.